Publications
Publications
  • February 2006 (Revised July 2007)
  • Case
  • HBS Case Collection

Corporate Venture Capital at Eli Lilly

By: Richard G. Hamermesh, Ron Laufer and David Lane
  • Format:Print
  • | Pages:16
ShareBar

Abstract

Reviews the role of corporate venture capital and its history at Eli Lilly. Also presents a challenging venture investment opportunity.

Keywords

Venture Capital; Investment; Pharmaceutical Industry

Citation

Hamermesh, Richard G., Ron Laufer, and David Lane. "Corporate Venture Capital at Eli Lilly." Harvard Business School Case 806-092, February 2006. (Revised July 2007.)

More from the Authors